Article
Three or four no-shows per day add up to as much as $1,000 per month, with no resulting revenue to the practice.
FDA awards orphan drug, rare pediatric disease designations to ABO-101 for PH1
Speaking of Urology: Dr. Finkelstein discusses telemedicine for pediatric post-op visits
Pediatric urinary microbiome composition is associated with recurrent UTI
Amanda J. Saraf, DO, shares ongoing research on oncofertility options for pediatric patients
ER utilization and overtreatment for UTI in pediatric patients with spina bifida
Dr. Laurence Baskin discusses robotic pediatric urological surgery at UCSF